Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6409
    -0.0016 (-0.25%)
     
  • OIL

    82.29
    -0.44 (-0.53%)
     
  • GOLD

    2,396.00
    -2.00 (-0.08%)
     
  • Bitcoin AUD

    101,127.62
    +5,071.63 (+5.28%)
     
  • CMC Crypto 200

    1,337.29
    +24.66 (+1.92%)
     
  • AUD/EUR

    0.6017
    -0.0013 (-0.22%)
     
  • AUD/NZD

    1.0892
    +0.0017 (+0.16%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,839.81
    -37.24 (-0.47%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,726.05
    -111.35 (-0.62%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Why Amarin Rose as Much as 7.9% Today

Why Amarin Rose as Much as 7.9% Today

Amarin (NASDAQ: AMRN) spiked nearly 8% on Tuesday before falling to earth and landing essentially flat over Monday's close. Amarin announced that the regulatory approval process for Vascepa has started in China and Hong Kong. On the mainland, the Chinese National Medical Products Administration has accepted a new drug application for the medicine.